This shift has spurred new research, innovation, and the creation of healthier and nutritional products
Additionally, a study published in The Lancet in February 2026 found that taking Foundayo, Eli Lillys GLP-1 pill that was approved by the FDA in April, resulted in greater weight loss and blood sugar level reductions compared to Rybelsus, another oral GLP-1 manufactured by Novo Nordisk
Detailed Product Description Retatrutide is a novel investigational medication classified as a triple hormone receptor agonist
De Herder Klppel
However, retatrutide may not be suitable for individuals with certain health conditions, such as severe gastrointestinal issues or heart problems
With a more convenient oral formulation, Novo can position itself as a competitor to traditional diabetes medications, such as metformin, sulfonylureas, and SGLT2 inhibitors that are taken by mouth